Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 88 (1-2) , 1-8
- https://doi.org/10.1016/s0165-5728(98)00040-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Role of nitric oxide synthesis in macrophage antimicrobial activityPublished by Elsevier ,2003
- Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivoLife Sciences, 1996
- Cytokines and Murine Autoimmune Encephalomyelitis: Inhibition or Enhancement of Disease with Antibodies to Select Cytokines, or by Delivery of Exogenous Cytokines Using a Recombinant Vaccinia Virus SystemScandinavian Journal of Immunology, 1995
- Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strainsPublished by Elsevier ,1994
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Journal of Clinical Investigation, 1994
- Astrocytic hypertrophy: An important pathological feature of chronic experimental autoimmune encephalitis in aged ratsJournal of Neuroimmunology, 1993
- Involvement of nitric oxide in basal and interleukin-1β-induced CRH and ACTH release in vitroLife Sciences, 1993
- Monoclonal Anti-Gamma Interferon Antibodies Enhance Experimental Allergic EncephalomyelitisAutoimmunity, 1993
- Nitric oxide control of steroidogenesis: Endocrine effects of NG-nitro-L-arginine and comparisons to alcoholLife Sciences, 1992
- Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.The Journal of Experimental Medicine, 1992